Drug Modeling Softwares Market, Global Outlook and Forecast 2023-2029

Report ID: MMG117259 | Category: Service & Software | Pages: 68 | Format: PDF | Published Date: July 12,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Drug Modeling has become an essential tool in the drug design process. Software based drug discovery and development methods are playing key a role in the development of novel drugs. Software based methods such as molecular modeling, structure-based drug design, structure-based virtual screening, ligand interaction and molecular dynamics are considered to be powerful tool for the investigation of pharmacokinetic and pharmacodynamic properties of drugs. These methods are fast, accurate, and provide valuable insights of experimental findings and mechanisms of action. Additionally, appropriate implementation of these techniques may help in reducing drug designing and development cost.
This report aims to provide a comprehensive presentation of the global market for Drug Modeling Softwares, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Modeling Softwares. This report contains market size and forecasts of Drug Modeling Softwares in global, including the following market information:
Global Drug Modeling Softwares Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Drug Modeling Softwares market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Database Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Drug Modeling Softwares include JSR Corporation(Crown Bioscience), Chemical Computing Group ULC, Nimbus Therapeutics, Schrodinger, Inc, Genedata AG, Biognos AB, Compugen Ltd, Dassault Systemes and Acellera, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drug Modeling Softwares companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drug Modeling Softwares Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Drug Modeling Softwares Market Segment Percentages, by Type, 2022 (%)
    Database
    Software
    Others
Global Drug Modeling Softwares Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Drug Modeling Softwares Market Segment Percentages, by Application, 2022 (%)
    Drug Discovery and Development
    Computational Physiological Medicine
    Disease Modelling
    Medical Imaging
    Predictive Analysis of Drug Targets
    Simulation Software
    Cellular Simulation
    Others
Global Drug Modeling Softwares Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Drug Modeling Softwares Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drug Modeling Softwares revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Drug Modeling Softwares revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    JSR Corporation(Crown Bioscience)
    Chemical Computing Group ULC
    Nimbus Therapeutics
    Schrodinger, Inc
    Genedata AG
    Biognos AB
    Compugen Ltd
    Dassault Systemes
    Acellera
    Instem(Leadscope)
Outline of Major Chapters:
Chapter 1: Introduces the definition of Drug Modeling Softwares, market overview.
Chapter 2: Global Drug Modeling Softwares market size in revenue.
Chapter 3: Detailed analysis of Drug Modeling Softwares company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Drug Modeling Softwares in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Drug Modeling Softwares Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Drug Modeling Softwares Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Drug Modeling Softwares Overall Market Size
    2.1 Global Drug Modeling Softwares Market Size: 2022 VS 2029
    2.2 Global Drug Modeling Softwares Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Drug Modeling Softwares Players in Global Market
    3.2 Top Global Drug Modeling Softwares Companies Ranked by Revenue
    3.3 Global Drug Modeling Softwares Revenue by Companies
    3.4 Top 3 and Top 5 Drug Modeling Softwares Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Drug Modeling Softwares Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Drug Modeling Softwares Players in Global Market
        3.6.1 List of Global Tier 1 Drug Modeling Softwares Companies
        3.6.2 List of Global Tier 2 and Tier 3 Drug Modeling Softwares Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Drug Modeling Softwares Market Size Markets, 2022 & 2029
        4.1.2 Database
        4.1.3 Software
        4.1.4 Others
    4.2 By Type - Global Drug Modeling Softwares Revenue & Forecasts
        4.2.1 By Type - Global Drug Modeling Softwares Revenue, 2018-2023
        4.2.2 By Type - Global Drug Modeling Softwares Revenue, 2024-2029
        4.2.3 By Type - Global Drug Modeling Softwares Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Drug Modeling Softwares Market Size, 2022 & 2029
        5.1.2 Drug Discovery and Development
        5.1.3 Computational Physiological Medicine
        5.1.4 Disease Modelling
        5.1.5 Medical Imaging
        5.1.6 Predictive Analysis of Drug Targets
        5.1.7 Simulation Software
        5.1.8 Cellular Simulation
        5.1.9 Others
    5.2 By Application - Global Drug Modeling Softwares Revenue & Forecasts
        5.2.1 By Application - Global Drug Modeling Softwares Revenue, 2018-2023
        5.2.2 By Application - Global Drug Modeling Softwares Revenue, 2024-2029
        5.2.3 By Application - Global Drug Modeling Softwares Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Drug Modeling Softwares Market Size, 2022 & 2029
    6.2 By Region - Global Drug Modeling Softwares Revenue & Forecasts
        6.2.1 By Region - Global Drug Modeling Softwares Revenue, 2018-2023
        6.2.2 By Region - Global Drug Modeling Softwares Revenue, 2024-2029
        6.2.3 By Region - Global Drug Modeling Softwares Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Drug Modeling Softwares Revenue, 2018-2029
        6.3.2 US Drug Modeling Softwares Market Size, 2018-2029
        6.3.3 Canada Drug Modeling Softwares Market Size, 2018-2029
        6.3.4 Mexico Drug Modeling Softwares Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Drug Modeling Softwares Revenue, 2018-2029
        6.4.2 Germany Drug Modeling Softwares Market Size, 2018-2029
        6.4.3 France Drug Modeling Softwares Market Size, 2018-2029
        6.4.4 U.K. Drug Modeling Softwares Market Size, 2018-2029
        6.4.5 Italy Drug Modeling Softwares Market Size, 2018-2029
        6.4.6 Russia Drug Modeling Softwares Market Size, 2018-2029
        6.4.7 Nordic Countries Drug Modeling Softwares Market Size, 2018-2029
        6.4.8 Benelux Drug Modeling Softwares Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Drug Modeling Softwares Revenue, 2018-2029
        6.5.2 China Drug Modeling Softwares Market Size, 2018-2029
        6.5.3 Japan Drug Modeling Softwares Market Size, 2018-2029
        6.5.4 South Korea Drug Modeling Softwares Market Size, 2018-2029
        6.5.5 Southeast Asia Drug Modeling Softwares Market Size, 2018-2029
        6.5.6 India Drug Modeling Softwares Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Drug Modeling Softwares Revenue, 2018-2029
        6.6.2 Brazil Drug Modeling Softwares Market Size, 2018-2029
        6.6.3 Argentina Drug Modeling Softwares Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Drug Modeling Softwares Revenue, 2018-2029
        6.7.2 Turkey Drug Modeling Softwares Market Size, 2018-2029
        6.7.3 Israel Drug Modeling Softwares Market Size, 2018-2029
        6.7.4 Saudi Arabia Drug Modeling Softwares Market Size, 2018-2029
        6.7.5 UAE Drug Modeling Softwares Market Size, 2018-2029
7 Drug Modeling Softwares Companies Profiles
    7.1 JSR Corporation(Crown Bioscience)
        7.1.1 JSR Corporation(Crown Bioscience) Company Summary
        7.1.2 JSR Corporation(Crown Bioscience) Business Overview
        7.1.3 JSR Corporation(Crown Bioscience) Drug Modeling Softwares Major Product Offerings
        7.1.4 JSR Corporation(Crown Bioscience) Drug Modeling Softwares Revenue in Global Market (2018-2023)
        7.1.5 JSR Corporation(Crown Bioscience) Key News & Latest Developments
    7.2 Chemical Computing Group ULC
        7.2.1 Chemical Computing Group ULC Company Summary
        7.2.2 Chemical Computing Group ULC Business Overview
        7.2.3 Chemical Computing Group ULC Drug Modeling Softwares Major Product Offerings
        7.2.4 Chemical Computing Group ULC Drug Modeling Softwares Revenue in Global Market (2018-2023)
        7.2.5 Chemical Computing Group ULC Key News & Latest Developments
    7.3 Nimbus Therapeutics
        7.3.1 Nimbus Therapeutics Company Summary
        7.3.2 Nimbus Therapeutics Business Overview
        7.3.3 Nimbus Therapeutics Drug Modeling Softwares Major Product Offerings
        7.3.4 Nimbus Therapeutics Drug Modeling Softwares Revenue in Global Market (2018-2023)
        7.3.5 Nimbus Therapeutics Key News & Latest Developments
    7.4 Schrodinger, Inc
        7.4.1 Schrodinger, Inc Company Summary
        7.4.2 Schrodinger, Inc Business Overview
        7.4.3 Schrodinger, Inc Drug Modeling Softwares Major Product Offerings
        7.4.4 Schrodinger, Inc Drug Modeling Softwares Revenue in Global Market (2018-2023)
        7.4.5 Schrodinger, Inc Key News & Latest Developments
    7.5 Genedata AG
        7.5.1 Genedata AG Company Summary
        7.5.2 Genedata AG Business Overview
        7.5.3 Genedata AG Drug Modeling Softwares Major Product Offerings
        7.5.4 Genedata AG Drug Modeling Softwares Revenue in Global Market (2018-2023)
        7.5.5 Genedata AG Key News & Latest Developments
    7.6 Biognos AB
        7.6.1 Biognos AB Company Summary
        7.6.2 Biognos AB Business Overview
        7.6.3 Biognos AB Drug Modeling Softwares Major Product Offerings
        7.6.4 Biognos AB Drug Modeling Softwares Revenue in Global Market (2018-2023)
        7.6.5 Biognos AB Key News & Latest Developments
    7.7 Compugen Ltd
        7.7.1 Compugen Ltd Company Summary
        7.7.2 Compugen Ltd Business Overview
        7.7.3 Compugen Ltd Drug Modeling Softwares Major Product Offerings
        7.7.4 Compugen Ltd Drug Modeling Softwares Revenue in Global Market (2018-2023)
        7.7.5 Compugen Ltd Key News & Latest Developments
    7.8 Dassault Systemes
        7.8.1 Dassault Systemes Company Summary
        7.8.2 Dassault Systemes Business Overview
        7.8.3 Dassault Systemes Drug Modeling Softwares Major Product Offerings
        7.8.4 Dassault Systemes Drug Modeling Softwares Revenue in Global Market (2018-2023)
        7.8.5 Dassault Systemes Key News & Latest Developments
    7.9 Acellera
        7.9.1 Acellera Company Summary
        7.9.2 Acellera Business Overview
        7.9.3 Acellera Drug Modeling Softwares Major Product Offerings
        7.9.4 Acellera Drug Modeling Softwares Revenue in Global Market (2018-2023)
        7.9.5 Acellera Key News & Latest Developments
    7.10 Instem(Leadscope)
        7.10.1 Instem(Leadscope) Company Summary
        7.10.2 Instem(Leadscope) Business Overview
        7.10.3 Instem(Leadscope) Drug Modeling Softwares Major Product Offerings
        7.10.4 Instem(Leadscope) Drug Modeling Softwares Revenue in Global Market (2018-2023)
        7.10.5 Instem(Leadscope) Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Drug Modeling Softwares Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?